{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:36:35Z","timestamp":1790649395056,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T00:00:00Z","timestamp":1416614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s11882-014-0489-6","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T13:07:30Z","timestamp":1417525650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":207,"title":["Update on Ankylosing Spondylitis: Current Concepts in Pathogenesis"],"prefix":"10.1007","volume":"15","author":[{"given":"Judith A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,22]]},"reference":[{"key":"489_CR1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MAJ.0b013e318294457f","volume":"345","author":"JD Reveille","year":"2013","unstructured":"Reveille JD, Weisman MH. The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci. 2013;345:431\u20136.","journal-title":"Am J Med Sci"},{"key":"489_CR2","author":"C Stolwijk","year":"2014","unstructured":"Stolwijk C, Essers I, van Tubergen A, Boonen A, Bazelier MT, et al. The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis. 2014. doi: 10.1136\/annrheumdis-2014-205253 .","journal-title":"Ann Rheum Dis"},{"key":"489_CR3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/berh.2002.0244","volume":"16","author":"A Boonen","year":"2002","unstructured":"Boonen A, Severens JL. Ankylosing spondylitis: what is the cost to society, and can it be reduced? Best Pract Res Clin Rheumatol. 2002;16:691\u2013705.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"489_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23:61\u20136.","journal-title":"Rheumatol Int"},{"key":"489_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.bor.0000159926.42761.dd","volume":"17","author":"A Anandarajah","year":"2005","unstructured":"Anandarajah A, Ritchlin CT. Treatment update on spondyloarthropathy. Curr Opin Rheumatol. 2005;17:247\u201356.","journal-title":"Curr Opin Rheumatol"},{"key":"489_CR6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.2003.016386","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis. 2004;63:665\u201370.","journal-title":"Ann Rheum Dis"},{"key":"489_CR7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","volume":"40","author":"MA Brown","year":"1997","unstructured":"Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823\u20138.","journal-title":"Arthritis Rheum"},{"key":"489_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10067-014-2662-7","volume":"33","author":"JD Reveille","year":"2014","unstructured":"Reveille JD. An update on the contribution of the MHC to as susceptibility. Clin Rheumatol. 2014;33:749\u201357.","journal-title":"Clin Rheumatol"},{"key":"489_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","volume":"57","author":"RA Colbert","year":"2014","unstructured":"Colbert RA, Tran TM, Layh-Schmitt G. HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol. 2014;57:44\u201351.","journal-title":"Mol Immunol"},{"key":"489_CR10","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3899\/jrheum.100889","volume":"37","author":"JD Taurog","year":"2010","unstructured":"Taurog JD. The role of HLA-B27 in spondyloarthritis. J Rheumatol. 2010;37:2606\u201316.","journal-title":"J Rheumatol"},{"key":"489_CR11","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.38644","volume":"66","author":"C Jeanty","year":"2014","unstructured":"Jeanty C, Sourisce A, Noteuil A, Jah N, Wielgosik A, et al. HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis. Arthritis Rheumatol. 2014;66:2113\u201323.","journal-title":"Arthritis Rheumatol"},{"key":"489_CR12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45:730\u20138. The largest GWAS to date, bringing a number of risk loci up to 31. This paper also includes an analysis comparing genetics of AS and other immune diseases.","journal-title":"Nat Genet"},{"key":"489_CR13","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1073\/pnas.1017854108","volume":"108","author":"R Sarin","year":"2011","unstructured":"Sarin R, Wu X, Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A. 2011;108:9560\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"489_CR14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43:761\u20137. Established epistatic interaction between ERAP1 and HLA-B27 which laid foundation for subsequent functional studies.","journal-title":"Nat Genet"},{"key":"489_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.coi.2008.09.003","volume":"20","author":"C Diveu","year":"2008","unstructured":"Diveu C, McGeachy MJ, Cua DJ. Cytokines that regulate autoimmunity. Curr Opin Immunol. 2008;20:663\u20138.","journal-title":"Curr Opin Immunol"},{"key":"489_CR16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","volume":"202","author":"CL Langrish","year":"2004","unstructured":"Langrish CL, McKenzie BS, Wilson NJ, de Waal MR, Kastelein RA, et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004;202:96\u2013105.","journal-title":"Immunol Rev"},{"key":"489_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/ard.2010.133322","volume":"70","author":"SI Davidson","year":"2011","unstructured":"Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, et al. Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis. 2011;70:289\u201392.","journal-title":"Ann Rheum Dis"},{"key":"489_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2013.05.065","volume":"436","author":"H Xu","year":"2013","unstructured":"Xu H, Chen X, Huang J, Deng W, Zhong Q, et al. Identification of GPR65, a novel regulator of matrix metalloproteinases using high through-put screening. Biochem Biophys Res Commun. 2013;436:96\u2013103.","journal-title":"Biochem Biophys Res Commun"},{"key":"489_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/TACG.S37325","volume":"7","author":"FW Tsui","year":"2014","unstructured":"Tsui FW, Tsui HW, Akram A, Haroon N, Inman RD. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis. Appl Clin Genet. 2014;7:105\u201315.","journal-title":"Appl Clin Genet"},{"key":"489_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2013.06.013","volume":"57","author":"PC Robinson","year":"2014","unstructured":"Robinson PC, Brown MA. Genetics of ankylosing spondylitis. Mol Immunol. 2014;57:2\u201311.","journal-title":"Mol Immunol"},{"key":"489_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nri3536","volume":"13","author":"V Lazarevic","year":"2013","unstructured":"Lazarevic V, Glimcher LH, Lord GM. T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol. 2013;13:777\u201389.","journal-title":"Nat Rev Immunol"},{"key":"489_CR22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/art.37936","volume":"65","author":"M Coffre","year":"2013","unstructured":"Coffre M, Roumier M, Rybczynska M, Sechet E, Law HK, et al. Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis. Arthritis Rheum. 2013;65:1510\u201321. This study began the investigation of interaction of IL-17\/IL-23 pathway risk alleles in controlling T helper gene expression.","journal-title":"Arthritis Rheum"},{"key":"489_CR23","first-page":"294","volume":"12","author":"H Mielants","year":"1985","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Botelberghe L. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol. 1985;12:294\u20138.","journal-title":"J Rheumatol"},{"key":"489_CR24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma\/delta T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 2012;64:1420\u20139.","journal-title":"Arthritis Rheum"},{"key":"489_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.smim.2009.01.002","volume":"21","author":"B Meresse","year":"2009","unstructured":"Meresse B, Cerf-Bensussan N. Innate T cell responses in human gut. Semin Immunol. 2009;21:121\u20139.","journal-title":"Semin Immunol"},{"key":"489_CR26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/BOR.0b013e3283620163","volume":"25","author":"MH Al-Mossawi","year":"2013","unstructured":"Al-Mossawi MH, Ridley A, Kiedel S, Bowness P. The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis. Curr Opin Rheumatol. 2013;25:434\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"489_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/ar4228","volume":"15","author":"ME Costello","year":"2013","unstructured":"Costello ME, Elewaut D, Kenna TJ, Brown MA. Microbes, the gut and ankylosing spondylitis. Arthritis Res Ther. 2013;15:214.","journal-title":"Arthritis Res Ther"},{"key":"489_CR28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","volume":"60","author":"F Ciccia","year":"2009","unstructured":"Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 2009;60:955\u201365.","journal-title":"Arthritis Rheum"},{"key":"489_CR29","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.34355","volume":"64","author":"F Ciccia","year":"2012","unstructured":"Ciccia F, Accardo-Palumbo A, Alessandro R, Rizzo A, Principe S, et al. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis Rheum. 2012;64:1869\u201378.","journal-title":"Arthritis Rheum"},{"key":"489_CR30","first-page":"534","volume":"118","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008;118:534\u201344.","journal-title":"J Clin Invest"},{"key":"489_CR31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/rheumatology\/ket323","volume":"53","author":"F Ciccia","year":"2014","unstructured":"Ciccia F, Alessandro R, Rizzo A, Accardo-Palumbo A, Raimondo S, et al. Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. Rheumatol (Oxford). 2014;53:104\u201313.","journal-title":"Rheumatol (Oxford)"},{"key":"489_CR32","doi-asserted-by":"crossref","unstructured":"Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, et al. Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol. 2014","DOI":"10.1007\/s10067-014-2652-9"},{"key":"489_CR33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","volume":"8","author":"JD Reveille","year":"2012","unstructured":"Reveille JD. Genetics of spondyloarthritis\u2014beyond the MHC. Nat Rev Rheumatol. 2012;8:296\u2013304.","journal-title":"Nat Rev Rheumatol"},{"key":"489_CR34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.rdc.2013.08.001","volume":"39","author":"GA Sanchez","year":"2013","unstructured":"Sanchez GA, de Jesus AA, Goldbach-Mansky R. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am. 2013;39:701\u201334.","journal-title":"Rheum Dis Clin North Am"},{"key":"489_CR35","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/art.24599","volume":"60","author":"JD Taurog","year":"2009","unstructured":"Taurog JD, Dorris ML, Satumtira N, Tran TM, Sharma R, et al. Spondylarthritis in HLA-B27\/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum. 2009;60:1977\u201384.","journal-title":"Arthritis Rheum"},{"key":"489_CR36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","volume":"10","author":"D Kontoyiannis","year":"1999","unstructured":"Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999;10:387\u201398.","journal-title":"Immunity"},{"key":"489_CR37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73:437\u201345. This study directly interrogated the role of biomechanical stress in promoting joint inflammation in the TNF \u0394ARE mouse model.","journal-title":"Ann Rheum Dis"},{"key":"489_CR38","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1002\/art.22077","volume":"54","author":"CK Edwards 3rd","year":"2006","unstructured":"Edwards 3rd CK, Bendele AM, Reznikov LI, Fantuzzi G, Chlipala ES, et al. Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha. Arthritis Rheum. 2006;54:2872\u201385.","journal-title":"Arthritis Rheum"},{"key":"489_CR39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","volume":"57","author":"HS Hreggvidsdottir","year":"2014","unstructured":"Hreggvidsdottir HS, Noordenbos T, Baeten DL. Inflammatory pathways in spondyloarthritis. Mol Immunol. 2014;57:28\u201337.","journal-title":"Mol Immunol"},{"key":"489_CR40","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/ard.2010.145946","volume":"70","author":"IH Song","year":"2011","unstructured":"Song IH, Heldmann F, Rudwaleit M, Haibel H, Weiss A, et al. Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study. Ann Rheum Dis. 2011;70:1108\u201310.","journal-title":"Ann Rheum Dis"},{"key":"489_CR41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/annrheumdis-2012-202177","volume":"73","author":"X Baraliakos","year":"2014","unstructured":"Baraliakos X, Baerlecken N, Witte T, Heldmann F, Braun J. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis. Ann Rheum Dis. 2014;73:1079\u201382. Description of relatively sensitive and specific autoantibodies in previously considered \u201cseronegative\u201d SpA.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"489_CR42","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/annrheumdis-2013-203630","volume":"73","author":"FW Tsui","year":"2013","unstructured":"Tsui FW, Tsui HW, Las Heras F, Pritzker KP, Inman RD. Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis. Ann Rheum Dis. 2013;73(10):1873\u20139. Implication of Wnt signaling and immune complexes in ankylosing spondylitis.","journal-title":"Ann Rheum Dis"},{"key":"489_CR43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10067-014-2663-6","volume":"33","author":"M Corr","year":"2014","unstructured":"Corr M. Wnt signaling in ankylosing spondylitis. Clin Rheumatol. 2014;33:759\u201362.","journal-title":"Clin Rheumatol"},{"key":"489_CR44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","volume":"62","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, et al. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010;62:150\u20138.","journal-title":"Arthritis Rheum"},{"key":"489_CR45","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","volume":"32","author":"SR Kwon","year":"2012","unstructured":"Kwon SR, Lim MJ, Suh CH, Park SG, Hong YS, et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Rheumatol Int. 2012;32:2523\u20137.","journal-title":"Rheumatol Int"},{"key":"489_CR46","doi-asserted-by":"crossref","first-page":"R216","DOI":"10.1186\/ar4055","volume":"14","author":"CG Saad","year":"2012","unstructured":"Saad CG, Ribeiro AC, Moraes JC, Takayama L, Goncalves CR, et al. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis Res Ther. 2012;14:R216.","journal-title":"Arthritis Res Ther"},{"key":"489_CR47","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","volume":"115","author":"RJ Lories","year":"2005","unstructured":"Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005;115:1571\u20139.","journal-title":"J Clin Invest"},{"key":"489_CR48","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","volume":"62","author":"IH Song","year":"2010","unstructured":"Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, et al. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum. 2010;62:1290\u20137.","journal-title":"Arthritis Rheum"},{"key":"489_CR49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/bi201230p","volume":"51","author":"JR Birtley","year":"2012","unstructured":"Birtley JR, Saridakis E, Stratikos E, Mavridis IM. The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing. Biochemistry. 2012;51:286\u201395.","journal-title":"Biochemistry"},{"key":"489_CR50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni1208","volume":"6","author":"L Saveanu","year":"2005","unstructured":"Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol. 2005;6:689\u201397.","journal-title":"Nat Immunol"},{"key":"489_CR51","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ni860","volume":"3","author":"IA York","year":"2002","unstructured":"York IA, Chang SC, Saric T, Keys JA, Favreau JM, et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol. 2002;3:1177\u201384.","journal-title":"Nat Immunol"},{"key":"489_CR52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/08916934.2013.819855","volume":"46","author":"SS Seregin","year":"2013","unstructured":"Seregin SS, Rastall DP, Evnouchidou I, Aylsworth CF, Quiroga D, et al. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity. 2013;46:497\u2013508.","journal-title":"Autoimmunity"},{"key":"489_CR53","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1074\/mcp.M112.019588","volume":"11","author":"N Garcia-Medel","year":"2012","unstructured":"Garcia-Medel N, Sanz-Bravo A, Van Nguyen D, Galocha B, Gomez-Molina P, et al. Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics. 2012;11:1416\u201329.","journal-title":"Mol Cell Proteomics"},{"key":"489_CR54","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.4049\/jimmunol.1400343","volume":"192","author":"A Akram","year":"2014","unstructured":"Akram A, Lin A, Gracey E, Streutker CJ, Inman RD. HLA-B27, but not HLA-B7, immunodominance to influenza is ERAP dependent. J Immunol. 2014;192:5520\u20138.","journal-title":"J Immunol"},{"key":"489_CR55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molimm.2013.06.012","volume":"57","author":"C Alvarez-Navarro","year":"2014","unstructured":"Alvarez-Navarro C, Lopez de Castro JA. ERAP1 structure, function and pathogenetic role in ankylosing spondylitis and other MHC-associated diseases. Mol Immunol. 2014;57:12\u201321.","journal-title":"Mol Immunol"},{"key":"489_CR56","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/rheumatology\/41.12.1375","volume":"41","author":"A Cauli","year":"2002","unstructured":"Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, et al. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatol (Oxford). 2002;41:1375\u20139.","journal-title":"Rheumatol (Oxford)"},{"key":"489_CR57","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012;18:1069\u201376. Landmark study showing sufficiency of IL-23 overexpression in driving SpA phenotype in mice.","journal-title":"Nat Med"},{"key":"489_CR58","doi-asserted-by":"crossref","unstructured":"Smith JA, Colbert RA. The IL-23\/IL-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. Arthritis Rheum. 2013.","DOI":"10.1002\/art.38291"},{"key":"489_CR59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2013.06.010","volume":"57","author":"JP Sherlock","year":"2014","unstructured":"Sherlock JP, Buckley CD, Cua DJ. The critical role of interleukin-23 in spondyloarthropathy. Mol Immunol. 2014;57:38\u201343.","journal-title":"Mol Immunol"},{"key":"489_CR60","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647\u201356.","journal-title":"Arthritis Rheum"},{"key":"489_CR61","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","volume":"186","author":"P Bowness","year":"2011","unstructured":"Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol. 2011;186:2672\u201380.","journal-title":"J Immunol"},{"key":"489_CR62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","volume":"64","author":"T Noordenbos","year":"2012","unstructured":"Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak PP, et al. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 2012;64:99\u2013109.","journal-title":"Arthritis Rheum"},{"key":"489_CR63","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","volume":"13","author":"H Appel","year":"2011","unstructured":"Appel H, Maier R, Wu P, Scheer R, Hempfing A, et al. Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther. 2011;13:R95.","journal-title":"Arthritis Res Ther"},{"key":"489_CR64","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.37937","volume":"65","author":"H Appel","year":"2013","unstructured":"Appel H, Maier R, Bleil J, Hempfing A, Loddenkemper C, et al. In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis. Arthritis Rheum. 2013;65:1522\u20139.","journal-title":"Arthritis Rheum"},{"key":"489_CR65","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","volume":"73","author":"F Ciccia","year":"2014","unstructured":"Ciccia F, Accardo-Palumbo A, Rizzo A, Guggino G, Raimondo S, et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann Rheum Dis. 2014;73:1566\u201374.","journal-title":"Ann Rheum Dis"},{"key":"489_CR66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454\u201360.","journal-title":"Nature"},{"key":"489_CR67","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, et al. Beta-glucan triggers spondylarthritis and Crohn\u2019s disease-like ileitis in SKG mice. Arthritis Rheum. 2012;64:2211\u201322.","journal-title":"Arthritis Rheum"},{"key":"489_CR68","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.38638","volume":"66","author":"H Benham","year":"2014","unstructured":"Benham H, Rehaume LM, Hasnain SZ, Velasco J, Baillet AC, et al. Interleukin-23 mediates the intestinal response to microbial beta-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol. 2014;66:1755\u201367.","journal-title":"Arthritis Rheumatol"},{"key":"489_CR69","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10067-014-2664-5","volume":"33","author":"JT Rosenbaum","year":"2014","unstructured":"Rosenbaum JT, Lin P, Asquith M, Costello ME, Kenna TJ, et al. Does the microbiome play a causal role in spondyloarthritis? Clin Rheumatol. 2014;33:763\u20137.","journal-title":"Clin Rheumatol"},{"key":"489_CR70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11926-002-0061-6","volume":"4","author":"F Keyser De","year":"2002","unstructured":"De Keyser F, Baeten D, Van den Bosch F, De Vos M, Cuvelier C, et al. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep. 2002;4:525\u201332.","journal-title":"Curr Rheumatol Rep"},{"key":"489_CR71","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/33.7.644","volume":"33","author":"O Martinez-Gonzalez","year":"1994","unstructured":"Martinez-Gonzalez O, Cantero-Hinojosa J, Paule-Sastre P, Gomez-Magan JC, Salvatierra-Rios D. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol. 1994;33:644\u20137.","journal-title":"Br J Rheumatol"},{"key":"489_CR72","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","volume":"180","author":"JD Taurog","year":"1994","unstructured":"Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359\u201364.","journal-title":"J Exp Med"},{"issue":"10","key":"489_CR73","first-page":"2780","volume":"66","author":"LM Rehaume","year":"2014","unstructured":"Rehaume LM, Mondot S. Aguirre de Carcer D, Velasco J, Benham H, et al. ZAP-70 genotype disrupts the relationship between microbiota and host leading to spondyloarthritis and ileitis. Arthritis. Rheumatol. 2014;66(10):2780\u201392. One of first published studies since germ-free HLA-B27 rat studies to interrogate a role of microbiome in some detail.","journal-title":"Rheumatol"},{"key":"489_CR74","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.febslet.2011.06.019","volume":"585","author":"GL Galea","year":"2011","unstructured":"Galea GL, Sunters A, Meakin LB, Zaman G, Sugiyama T, et al. Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4. FEBS Lett. 2011;585:2450\u20134.","journal-title":"FEBS Lett"},{"key":"489_CR75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bone.2011.10.025","volume":"50","author":"X Tu","year":"2012","unstructured":"Tu X, Rhee Y, Condon KW, Bivi N, Allen MR, et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone. 2012;50:209\u201317.","journal-title":"Bone"},{"key":"489_CR76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2007.071605","volume":"67","author":"S Visvanathan","year":"2008","unstructured":"Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, et al. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis. 2008;67:511\u20137.","journal-title":"Ann Rheum Dis"},{"key":"489_CR77","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar3766","volume":"14","author":"FK Lekpa","year":"2012","unstructured":"Lekpa FK, Poulain C, Wendling D, Soubrier M, De Bandt M, et al. Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study. Arthritis Res Ther. 2012;14:R53.","journal-title":"Arthritis Res Ther"},{"key":"489_CR78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/annrheumdis-2012-202470","volume":"72","author":"MM Schoels","year":"2013","unstructured":"Schoels MM, van der Heijde D, Breedveld FC, Burmester GR, Dougados M, et al. Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement. Ann Rheum Dis. 2013;72:583\u20139.","journal-title":"Ann Rheum Dis"},{"key":"489_CR79","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","volume":"373","author":"A Gottlieb","year":"2009","unstructured":"Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, et al. Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet. 2009;373:633\u201340. Important proof of concept study for relevance of IL-17\/IL-23 pathway in AS pathogenesis.","journal-title":"Lancet"},{"issue":"5","key":"489_CR80","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","volume":"73","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy D, Hermann KG, Callhoff J, Listing J, Sieper J. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis. 2014;73(5):817\u201323.","journal-title":"Ann Rheum Dis"},{"key":"489_CR81","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2013;382:1705\u201313. Proof of concept for importance of IL-17 in AS pathogenesis.","journal-title":"Lancet"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0489-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-014-0489-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0489-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T22:35:39Z","timestamp":1566081339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-014-0489-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,22]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s11882-014-0489-6","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,22]]},"article-number":"489"}}